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Abstract. We conducted a cross-sectional study to investigate the clinical factors
associated with mortality in patients with dengue viral infection at a tertiary care
center over a 3 year period. Six hundred ninety-nine patients with a clinical diag-
nosis of dengue fever (DF), dengue hemorrhagic fever (DHF) and dengue shock
syndrome (DSS) during the study period were included in the study. Data were
collected with a predesigned form comprised of demographics, duration of fever,
associated symptoms, diagnosis of DF, DHF and DSS, and laboratory parameters
[complete blood count, coagulation tests, creatinine, serum glutamic pyruvic tran-
saminase (SGPT)]; dengue IgM was checked in all patients by ELISA. Outcomes
(survival/mortality) and complications were recorded. Mortality was the primary
outcome measure. DF constituted 86.4% (604), DHF constituted 11.6% (81) and
DSS constituted 2% (14) of patients. The mortality rate was 2.7% (19). The mean
white blood cell count in those who died was 13.3, in those who survived was 5.3,
the difference was significant (p=0.02). The mean BUN in those who died was
33.2, those who survived was 13.8, (p=0.007). The mean bicarbonate level in those
who died was 17.1, those who survived was 18.5 (p <0.001). Mean activated par-
tial thromboplastin time in those who died was 56.8, those who survived was 36.8
(p=0.01). The mean SGPT in those who died was 802, those who survived was 176
(p=0.01). Those who died were significantly (p <0.001) more likely to have severe
hepatitis (63%) than those who survived (13.8%). On multivariate logistic regres-
sion analysis, having an SGPT > 300 mg/dl, bleeding, an altered mental status and
shock at presentation  were all significantly associated with  mortality in patients
with dengue virus infection (p=0.008, p<0.001, p<0.001, p<0.001, respectively).
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ing in 24,000 deaths are reported world-
wide with the numbers increasing annu-
ally (Barboza et al, 2008; Itrat et al, 2008).
Epidemics of dengue virus infection are
witnessed sporadically throughout the
tropics and dengue is endemic in South-
east Asia and India. Recently it has become
endemic in Pakistan, with cases seen in
major hospitals all year round (Wasay
et al, 2008).
INTRODUCTION
Every year 50-100 million cases of
dengue fever (DF) and 500,000 cases of
dengue hemorrhagic fever (DHF), result-
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Dengue leads to a spectrum of symp-
toms in humans including a mild flu like
illness, the colloquial “break-bone” fever,
DHF and dengue shock syndrome (DSS).
A recent study done in a tertiary care hos-
pital in Pakistan showed cases of DHF and
DSS are on the rise (Wasay et al, 2008). No
specific treatment exists for dengue
(Ahsan, 2008). Only supportive care can
be provided to patients, this includes fre-
quent monitoring of platelet levels and
replacement as needed along with replace-
ment of other blood products when nec-
essary. Hematocrits, liver transaminases
and electrolytes should also be monitored.
Fever should be controlled with acetami-
nophen (paracetamol) and sponging,
while NSAIDs should be avoided (Kabra
et al, 1999).
Although inadequate supportive care
may be an issue in some hospitals, which
contributes to the morbidity and mortal-
ity in some patients with dengue fever,
there are several risk factors that are asso-
ciated with poor patient outcomes and
mortality. Several predictors of mortality
have been identified. In a study done in
Taiwan the chances of mortality due to
dengue infection are higher in the elderly
(Lee et al, 2008). A study done in Singapore
revealed the presence of any chronic dis-
ease is associated with poorer outcomes
(Lahiri et al, 2008). These included renal
disease (Kuo et al, 2008; Lee et al, 2008) and
chronic obstructive pulmonary disease
(Lee et al, 2008). The study done in Taiwan
mentioned above found secondary bacte-
remia contributes to death as well (Lahiri
et al, 2008). A study done in the Philippines
revealed prolongation of PTT was associ-
ated with an increased likelihood of fatal
bleeding (Chua et al, 1993). In recent years
in Pakistan, dengue infection has taken
the form of an epidemic and has been as-
sociated with poor outcomes; data is scarce
regarding the factors associated with mor-
tality in dengue infection. We therefore
conducted this study to investigate the
relationships between clinical factors as-
sociated with mortality in patients with
dengue viral infection at a tertiary care
center.
MATERIALS AND METHODS
We conducted a cross-sectional study,
in patients with dengue viral infection
admitted to our tertiary care center over a
3 year period from the emergency room
or clinic to the medicine wards of Aga
Khan University Hospital. Ethical clear-
ance was obtained for the study from the
Institutional Ethical Review Committee
(ERC/06-11-07).
We included all patients admitted
with a diagnosis of DF, DHF or DSS age
greater than 14 years old and a positive
ELISA test for dengue IgM. DF is charac-
terized by sudden onset fever and a vari-
ety of nonspecific signs and symptoms,
including frontal headache, retro-orbital
pain, body aches, nausea and vomiting,
joint pains, weakness, and rash. DHF  is
characterized by sudden onset fever, last-
ing 2 to 7 days, with signs of circulatory
failure or hemorrhagic manifestations
occuring from about 24 hours before to
24 hours after the temperature falls to nor-
mal or below normal. Common hemor-
rhagic manifestations include skin hemor-
rhages, such as petechiae, purpuric lesions,
and ecchymoses. Epistaxis, bleeding gums,
gastrointestinal hemorrhage and hema-
turia occur less frequently (Hayes and
Gubler, 1992). DSS is characterized by a
rapid, weak pulse with a narrowing pulse
pressure of less than 20 mmHg, or pro-
found hypotension (systolic blood pres-
sure less than 90 mmHg among those five
years of age or older) (Gibbons and
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Vaughn, 2002). Those with dengue viral
infection along with malaria or typhoid
fever and who were transferred to another
hospital due to unavailability of beds were
excluded from the study.
Data were collected on a predesigned
form consisted of demographics, duration
of fever and associated symptoms (diar-
rhea, vomiting, cough, rash, bleeding gums,
hematemasis, melena, hematochezia, ab-
dominal pain, shortness of breath, general-
ized body aches, and red conjunctiva).
Other data included  diagnosis (eg, DF,
DHF, DSS), laboratory results (complete
blood count, coagulation tests, creatinine,
and serum glutamic pyruvic transaminase
(SGPT); dengue IgM (ELISA) was checked
in all patients. Outcomes (survival/mortal-
ity) and complications during the inpatient
stay were recorded.
A minimum sample size of 115 pa-
tients with dengue viral infection was re-
quired to predict factors for mortality with
dengue infection. For testing beta coeffi-
cients the following was used: n=104+k,
where k = number of independent vari-
ables (Tabachnick, 2005).
Statistical analysis
Mortality was the primary outcome
measure. Demographics, clinical presen-
tation, lab workup (complete blood count,
SGPT, coagulation tests, and creatinine)
were independent variables. Analysis was
done using SPSS version 15. Means and
standard deviations were calculated for
quantitative variables and frequencies and
percentages for qualitative variables. The
chi-square test was used to see the asso-
ciation among qualitative variables, such
as gender and fever with outcome vari-
ables. The Student’s t- test was used to see
the differences in quantitative variable,
such as age and blood pressure  with  out-
come variables.
Multiple logistic regression was used
to predict a model of factors associated
with  mortality in patients with dengue
fever. Univariate analysis was done of in-
dependent variables and outcome mortal-
ity (dichotomous). Only those variables
were used for univariate analysis which
had some biological plausibility with the
outcome. Those variables with a p-value
<0.05 on univariate logistic regression
were run in the multivariable model.
Those found insignificant were then
checked for interaction and confounding
and based on this were excluded from the
model if they had no significant interac-
tions and were not confounders. The
model was checked for goodness of fit
with the Hosmer-Lemeshow test.
RESULTS
A total of 699 patients were admitted
with the clinical diagnosis of dengue viral
infection. DF comprised 86.4% (604) of
cases, DHF comprised 11.6% (81) and DSS
comprised 2% (14). The mean age of the
patients was 31.9 years. The mean dura-
tion of fever was 6.1 ± 3 days. Sixty per-
cent were males. The most common asso-
ciated symptom with fever was nausea
and vomiting (48.6%, 340), followed by
abdominal pain (18.2%, 127), rash (16.7%,
117), body aches (15.9%, 111), diarrhea
(10.2%, 71), cough (9.4%, 66), hematemasis
(5.7%, 40), bleeding gums (5.2%, 36), mel-
ena (4.3%, 30), altered mental status (3.7%,
29) and  jaundice (3.1%, 22).
Primary outcome measure (mortality)
The mortality rate was 2.7% (19).
When comparing the clinical presentation
of those who survived and those who did
not, the significant differences were dura-
tion of fever (4.31 and 6.14 days; p=0.004),
jaundice (21.1% and 2.7%; p=0.002) and
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altered mental status (47.4% and 2.5%;
p<0.001), respectively. The overall lab re-
sults and comparisons between those who
survived and those who did not are shown
in Table 1. The significant differences be-
tween those who died and those who sur-
vived included white blood cell counts
(WBC) (13.30 and 5.31; p=0.02), BUN (33.23
and 13.82; p=0.007), bicarbonate (17.09 and
23.98; p<0.001), APTT (56.75 and 36.83;
p=0.01), SGPT (802 and 176; p=0.01), and
the presence of severe hepatitis (63% and
13.8%; p<0.001), respectively.
On univariate logistic regression
analysis, hematocrit (p=0.02), APTT
(p=0.04), severe hepatitis (p=0.05), bleed-
ing (p<0.001), renal failure (p<0.001), al-
tered mental status (p <0.001), and shock
(p <0.001) were significantly associated
with mortality. On multivariate logistic
regression (Table 2), SGPT >300 mg/dl
(p=0.008), bleeding (p<0.001), altered
mental status (p<0.001) and shock
(p<0.001) were significantly associated
Lab parameter Overall ± SD Mortality Survival p-value
N=699 mean N=19 N= 680
± SD ± SD
Hb 13.71 2.37 12.17 13.75 0.10
4.05 2.30
Ht 39.59 7.80 34.94 39.72 0.06
 10.41 7.68
WBC 5.53 5.50 13.30 5.31 0.02
13.61 4.93
Platelets 67.16 59.54 60.47 67.35 0.51
43.99 59.94
BUN 14.46 14.62 33.23 13.82 0.007
25.58 13.69
Creatinine 1.92 9.52 1.8 1.92 0.39
 0.92  9.67
Bicarbonate 23.70 18.17 17.09  23.98 <0.001
4.87  18.47
Prothrombin time 13.02 4.62 27.18 15.72 0.06
 23.13 55.12
Activated partial thrombin time 36.50 12.28 56.75 36.83 0.01
31.18 19.91
SGPT 194.87 351.93 802.78 176.85 0.012
976.72 299.01
SGPT Mild to moderate (23-299) 71% (496) 31.6% (6) 76% (490) <0.001
Severe hepatitis (>300) 14.7% (103) 63.2% (12) 13.8% (91)
Normal 8.3% (58) 5.3% (1) 9% (57)
SGOT 436.76 987.47 2,569.11 372 0.022
3,555.81 711.55
Table 1
Comparision of mortality and survival groups in dengue viral infection.
Hb, hemoglobin; Ht, hematocrit
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Exp(β) Significanceb Exp(β) Significanceb Hosmer-
coefficient coefficient Lemeshow
Hematocrit 1.05 0.02
APTTa 2.62 0.04
SGPT groupa <0.001
Dummy 1 0.09 0.74
Dummy 2 0.69 0.05 0.122 0.008
Plateletsc 0.90 0.85
Bleeding 0.007 <0.001 0.003 <0.001 p-value  0.23
Pulse pressure 0.99 0.9
Altered mental statusd 37.09 <0.001 131.2 <0.001
Renal failure 0.011 <0.001
Shock 0.02 <0.001 0.008 <0.001
HCO3
e 1.40 0.53
Table 2
Factors associated with mortality in dengue viral infection.
aAPTT, <34 and >34; bSGPT, 23-300, >300, normal (<23); cPlatelet, <100 and >100;
dAltered mental status, normal, abnormal (drowsy, confused , comatose); eHCO3, <18, >18
Exp (β) coefficient: odds of mortality for each unit change in predictor
with mortality in patients with dengue
virus infection.
DISCUSSION
Severe hepatitis (SGPT > 300), history
of bleeding, altered mental status on ad-
mission and shock were the best predic-
tors of mortality in patients with dengue
viral infection. We report the clinical fac-
tors associated with mortality in an evalu-
ation of the largest number of cases of den-
gue infection from the Indo Asian region.
Many studies have evaluated individual
predictors of mortality, while we report
these together in one model.
The presence of shock, coma on pre-
sentation and seizures were previously
reported as important predictors of mor-
tality in dengue infection (Wasay et al,
2008). On multivariate analysis  in elderly
patients, DSS (odds ratio = 77.33, p=0.001)
was found to be an independent risk fac-
tor for mortality (Lee et al, 2008). Shock has
been reported previously as an important
factor for mortality with or without a his-
tory of associated blood loss. Vascular col-
lapse (shock) was present in 12 (85.7%)
cases, with or without the association of
major bleeding, and was the most impor-
tant cause of death (Montenegro et al,
2006).  Shock  in itself is an alarming pre-
sentation in patients with  dengue virus
infection and as an indicator  of the sever-
ity of disease in a case series of 23 patients
from Puerto Rico (Rigau-Perez and Laufer,
2006). Shock in those patients was related
to bleeding diathesis in most cases.
Spontaneous bleeding is a fairly com-
mon complication in dengue patients and
is associated with increased mortality
(Diaz-Quijano, 2008).  Several mechanisms
Univariate Multi variate
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have been discussed to account for the
bleeding in dengue infection. Thrombocy-
topenia,  coagulopathies and hepatic alter-
ations are associated with bleeding (Diaz-
Quijano, 2008).The platelet counts may be
predictors of mortality: the risk for death
is 6 times greater in those with a platelet
count <50,000/µl than in those with a plate-
let count >50,000/µl in the pediatric popu-
lation (Chua et al, 1993).
We found a significant association
between encephalopathy and hepatitis.
Encephalopathy is significantly associated
with mortality in dengue infection. Sev-
eral factors may be responsible for the high
percentage of encephalopathy cases in this
study. Hepatitis may be a cause of en-
cephalopathy in these patients. Acute
hepatitis and hepatic encephalopathy have
been reported as rare manifestations of
DHF (Shah, 2008). Acute liver failure is
the most common cause of encephalopa-
thy in patients with dengue infection
(Montenegro et al, 2006). In contrast to
other viral infections which involve the
liver, the AST (SGOT) levels were much
higher than ALT (SGOT) levels as de-
scribed by others (Kuo et al, 1997). This
difference could be due to the release of
AST (SGOT) from skeletal muscle and the
myocardium as damage to muscle in den-
gue infections has been reported (Davis
and Bourke, 2004). The reverse ratio could
be hypothesised to contribute to the en-
cephalopathy. It is unclear whether hepa-
titis alone can explain the encephalopathy
observed. Hepatitis, with transaminase
levels, occurred in the majority of patients,
who were generally anicteric. The dengue
virus itself may be responsible for en-
cephalopathy. DHF causes a clinical spec-
trum that infrequently involves encepha-
litis due to a direct neurotropic effect of
dengue virus (Cam et al, 2001). Secondary
infection in patients with dengue infection
may also contribute to encephalopathy in
these patients.
In evaluating individual lab param-
eters, we found mortality due to dengue
viral infection was significantly associated
with a high white cell count, uremia, aci-
dosis and deranged liver function. A high
white cell count indicates an associated
bacterial infection. Dengue infection usu-
ally causes leukopenia (Ahmed et al, 2008).
Secondary bacterial infection on presenta-
tion has been postulated to  be a predictor
of death from dengue (Lahiri et al, 2008).
We did not investigate the type of bacte-
rial infection the patients had, these infec-
tions lead to hypothesis dengue infection
makes patients more susceptible to bacte-
rial infection. More studies are needed to
evaluate this hypothesis and assess the
role of antibiotics in high risk patients with
dengue infection. Both acute and chronic
renal failure are associated with mortality
in dengue infection (Kuo et al, 2008).  Acute
renal failure has a worse prognosis in the
elderly with dengue infection (Lee et al,
2008). Metabolic acidosis in these patients
may be associated with renal failure and
shock. Prolonged shock is associated  with
metabolic acidosis and DIC which may
lead to hypoxia/ischemia and results in
both hepatic and cerebral dysfunction
(Nimmannitya et al, 1978). Metabolic aci-
dosis is found significantly more often in
patients with DSS than DHF (Kasim et al,
1991).
A strength of our study was that it was
the largest dataset of patients with den-
gue infection reported from the Indo Asian
region which identified the clinical factors
associated with   mortality at a tertiary care
center in a multivariate model. Previously,
only associations with individual factors
were reported. All patients with serology
proving dengue infection were included
in the study. There were several limitations
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to our study. It was a single center study
and has limited external validity. We did
not account for confounders, such as as-
sociated comorbidity or infections.
In summary, severe hepatitis (SGPT
> 300), a history of bleeding, altered men-
tal status on admission  and shock were
clinical factors associated with mortality
on patients with dengue viral infection. We
recommend patients with dengue infec-
tion with such predictors of mortality on
presentation warrant management in high
dependency units.
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